Continuing in their long-term collaboration in data management in multiple myeloma, EMOL is proud to announce the contribution of its Founder & CEO, Brian Decker in the recently published Study Assessing the All4Cure Health Technology Intervention on Patient Activation in Multiple Myeloma found in the ASH Publication, Blood 2023; 142 (Supplement 1): 3375.

For Article link, click here.